Showing results (671-680 of 1,007) with videos related to

Sort By:
Pageof 101
Bulletin of Environmental Contamination and Toxicology|October 12, 2012
Alterations in morphometric and organosomatic indices and histopathological analyses indicative of environmental contamination in Mullet, Mugil liza, from Southeastern BrazilR A Hauser-Davis, R C Lavandier, F F Bastos, et al.
Neurology|January 31, 2024
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled TrialCynthia L Comella, Joseph Jankovic, Robert A Hauser, et al.
Journal of Parkinson'S Disease|May 14, 2019
Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal TrialsRobert A Hauser, Daniel E Kremens, Lawrence W Elmer, et al.
Molecular Vision|May 1, 2010
Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African populationSusan E I Williams, Benjamin T Whigham, Yutao Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1989
Lineage-restricted expression of homeobox-containing genes in human hematopoietic cell linesW F Shen, C Largman, P Lowney, et al.
Archives of Neurology|August 26, 1998
Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group IIIC H Adler, C Singer, C O'Brien, et al.
Molecular Neurobiology|April 16, 2020
A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich's Ataxia PatientsJulia O Misiorek, Anna M Schreiber, Martyna O Urbanek-Trzeciak, et al.
Clinical Pharmacokinetics|May 20, 2018
Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of DyskinesiaRobert A Hauser, Rajesh Pahwa, William A Wargin, et al.
Genome Biology and Evolution|June 28, 2019
Complete Genomes of Symbiotic Cyanobacteria Clarify the Evolution of Vanadium-NitrogenaseJessica M Nelson, Duncan A Hauser, José A Gudiño, et al.
The Journal of Biological Chemistry|April 5, 1996
Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformationC K Galang, J García-Ramírez, P A Solski, et al.
Pageof 101